The Cdk inhibitor flavopiridol enhances temozolomide-induced cytotoxicity in human glioma cells

Author： Hayashi Takuro   Adachi Kazuhide   Ohba Shigeo   Hirose Yuichi  

Publisher： Springer Publishing Company

ISSN： 0167-594X

Source： Journal of Neuro-Oncology, Vol.115, Iss.2, 2013-11, pp. : 169-178

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Specific mTOR inhibitor rapamycin enhances cytotoxicity induced by alkylating agent 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea (ACNU) in human U251 malignant glioma cells

By Tanaka Kazuhiro   Sasayama Takashi   Mizukawa Katsu   Kawamura Atsufumi   Kondoh Takeshi   Hosoda Kohkichi   Fujiwara Toshiyoshi   Kohmura Eiji  

Journal of Neuro-Oncology, Vol. 84, Iss. 3, 2007-09 ,pp. : 233-244

Springer Publishing Company

Access to resources Recommend Favorite

Bowman-Birk protease inhibitor from soybeans enhances cisplatin-induced cytotoxicity in human mesothelioma cells

By              

Experimental and Therapeutic Medicine, Vol. 2, Iss. 4, 2011-01 ,pp. : 719-724

Spandidos Publications

Access to resources Recommend Favorite

Knockdown of Nrf2 enhances autophagy induced by temozolomide in U251 human glioma cell line

By                  

Oncology Reports, Vol. 29, Iss. 1, 2013-01 ,pp. : 394-400

Spandidos Publications

Access to resources Recommend Favorite

NF-κB inhibitor reverses temozolomide resistance in human glioma TR/U251 cells

By                

Oncology Letters, Vol. 9, Iss. 6, 2015-01 ,pp. : 2586-2590

Spandidos Publications

Access to resources Recommend Favorite

LY294002 enhances cytotoxicity of temozolomide in glioma by down-regulation of the PI3K/Akt pathway

By                    

Molecular Medicine Reports, Vol. 5, Iss. 2, 2012-01 ,pp. : 575-579

Spandidos Publications

Access to resources Recommend Favorite